YasminHasanMD

Radiation Oncology • Chicago, IL

Breast Cancer, Gynecologic Cancer, Hematologic Malignancies

Director of gynecological radiation oncology and brachytherapy

Join to view full profile

Dr. Hasan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hasan's full profile

Already have an account?

Office
5841 S Maryland Ave
Chicago, IL 60637
Phone+1 888-824-0200

Education & Training

Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2003

Certifications & Licensure

IL State Medical License 2008 - 2026
IN State Medical License 2024 - 2025
MI State Medical License 2003 - 2008
PA State Medical License 2007 - 2007
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

A Study of INO-3112 DNA Vaccine With Electroporation in Participants With Cervical Cancer Start of enrollment: 2014 Jun 06
Completed
Phase 1, Phase 2
A Phase II Clinical Trial of Chemo-radiotherapy in Combination With INO-3112 in Patients With Locally Advanced Cervical Cancer Start of enrollment: 2016 May 01
Withdrawn
Phase 2
Radiation Dose Study for Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma Start of enrollment: 2021 Sep 30
Recruiting
Not Applicable
Roles: Contact, Principal Investigator
Hypofractionation (Radiation) Trial for Multiple Myeloma Start of enrollment: 2024 May 01
Not yet recruiting
Phase 1
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

119 citations
Clinical outcomes of intensity-modulated pelvic radiation therapy for carcinoma of the cervix.
Michael D. Hasselle, Brent S. Rose, J.D. Kochanski, Sameer K. Nath, Rounak Bafana
International Journal of Radiation Oncology, Biology, Physics. 2011-08-01
65 citations
The efficacy and safety of continued hydroxycarbamide therapy versus switching to ruxolitinib in patients with polycythaemia vera: a randomized, double-blind, double-d...
Ruben A. Mesa, Alessandro M. Vannucchi, Abdulraheem Yacoub, Pierre Zachee, Mamta Garg
British Journal of Haematology. 2017-01-01
22 citations
Outcomes for patients with cervical cancer treated with extended-field intensity-modulated radiation therapy and concurrent cisplatin.
Lindsay G. Jensen, Michael D. Hasselle, Brent S. Rose, Sameer K. Nath, Yasmin Hasan
International Journal of Gynecological Cancer. 2013-01-01

Lectures

A phase 1/2A trial of synthetic DNA vaccine immunotherapy targeting HPV-16 and -18 after chemoradiation for cervical cancer.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

Northwest Indiana Girl Capable of Get Therapy near Residence for Her Uncommon, Aggressive Uterine Most CancersDecember 12th, 2022
Study Finds Stereotactic Body Radiotherapy Is Safe for Treating Patients with Multiple MetastasesApril 21st, 2021